Search results
Strength in Vista Segment Aids Cimpress (CMPR) Amid Cost Woes
Zacks· 3 days agoFree Report) is gaining strength across the Vista, National Pen and Upload & Print segments. Its Vista segment is being aided by robust demand for signage ...
Top Analyst Reports for Novo Nordisk, TotalEnergies & U.S. Bancorp
Zacks via Yahoo Finance· 3 days agoToday's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 8 hours agoNight Vision Devices Market size is set to grow by USD 3.56 billion from 2024-2028, Increased applications in military operations boost the market, Technavio PR Newswire NEW YORK, June 9, 2024 NEW YORK, June 9, 2024 /PRNewswire/ -- The global night
Solano Land Trust opposes California Forever due to environmental harm fears, claims of "misleading"...
CBS News· 3 days agoThe board of directors wanted to make sure they all researched their stance well, weighing each...
ITA Group, amid more than 500% growth, plans move to bigger office in West Des Moines
The Des Moines Register via Yahoo Finance· 7 days agoITA is currently headquartered at 4600 Westown Parkway but will moving to the Arcadia Building at...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 11 hours agoCycling Wear Market size is set to grow by USD 1.81 billion from 2024-2028, Increased adoption of cycling to maintain fitness boost the market, Technavio PR Newswire NEW YORK, June 9, 2024 NEW YORK, June 9, 2024 /PRNewswire/ -- The global cycling
The true nature of biophilic interior design | Produced by Seattle Times Marketing
Seattle Times· 3 days agoBiophilic interior design is an innovative philosophy that incorporates natural elements into indoor...
GOP Senate candidate puffs up hemp business claims
Politico· 4 days agoKion was most recently director of storytelling at Jay-Z’s REFORM Alliance...
How Austin-based Wonderbelly secured shelf presence in 5,500 CVS stores - Austin Business Journal
The Business Journals· 7 days agoThe first rule for a successful consumer packaged goods business is to identify a unique product —...
FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate...
Benzinga· 7 days agoFibroGen to evaluate FG-3165, an anti-galectin 9 (Gal9) monoclonal antibody (mAb), as monotherapy treatment as well as in combination with LIBTAYO® in patients with select solid tumorsFibroGen to evaluate FG-3175,
